171 related articles for article (PubMed ID: 29575648)
1. Spontaneous development of intratumoral heterogeneity in a transposon-induced mouse model of glioma.
Sumiyoshi K; Koso H; Watanabe S
Cancer Sci; 2018 May; 109(5):1513-1523. PubMed ID: 29575648
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
Connolly NP; Stokum JA; Schneider CS; Ozawa T; Xu S; Galisteo R; Castellani RJ; Kim AJ; Simard JM; Winkles JA; Holland EC; Woodworth GF
PLoS One; 2017; 12(3):e0174557. PubMed ID: 28358926
[TBL] [Abstract][Full Text] [Related]
3. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
4. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
5. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
6. Genetic modeling of gliomas in mice: new tools to tackle old problems.
Hambardzumyan D; Parada LF; Holland EC; Charest A
Glia; 2011 Aug; 59(8):1155-68. PubMed ID: 21305617
[TBL] [Abstract][Full Text] [Related]
7. PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.
Xu R; Ji J; Zhang X; Han M; Zhang C; Xu Y; Wei Y; Wang S; Huang B; Chen A; Zhang D; Zhang Q; Li W; Jiang Z; Wang J; Li X
J Exp Clin Cancer Res; 2017 Dec; 36(1):193. PubMed ID: 29282077
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice.
Qin Y; Musket A; Kou J; Preiszner J; Tschida BR; Qin A; Land CA; Staal B; Kang L; Tanner K; Jiang Y; Schweitzer JB; Largaespada DA; Xie Q
Neurooncol Adv; 2020; 2(1):vdaa067. PubMed ID: 32642717
[TBL] [Abstract][Full Text] [Related]
9. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
10. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system.
Garcia-Fabiani MB; Comba A; Kadiyala P; Haase S; Núñez FJ; Altshuler D; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 632():369-388. PubMed ID: 32000905
[TBL] [Abstract][Full Text] [Related]
12. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality.
Collier LS; Adams DJ; Hackett CS; Bendzick LE; Akagi K; Davies MN; Diers MD; Rodriguez FJ; Bender AM; Tieu C; Matise I; Dupuy AJ; Copeland NG; Jenkins NA; Hodgson JG; Weiss WA; Jenkins RB; Largaespada DA
Cancer Res; 2009 Nov; 69(21):8429-37. PubMed ID: 19843846
[TBL] [Abstract][Full Text] [Related]
13. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
14. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
Martinho O; Longatto-Filho A; Lambros MB; Martins A; Pinheiro C; Silva A; Pardal F; Amorim J; Mackay A; Milanezi F; Tamber N; Fenwick K; Ashworth A; Reis-Filho JS; Lopes JM; Reis RM
Br J Cancer; 2009 Sep; 101(6):973-82. PubMed ID: 19707201
[TBL] [Abstract][Full Text] [Related]
15. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.
Huang Y; Hoffman C; Rajappa P; Kim JH; Hu W; Huse J; Tang Z; Li X; Weksler B; Bromberg J; Lyden DC; Greenfield JP
Cancer Res; 2014 Feb; 74(4):1011-21. PubMed ID: 24371228
[TBL] [Abstract][Full Text] [Related]
17. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a green fluorescent protein tracing murine model focused on the functions of host components in necrosis repair and the niche of subcutaneously implanted glioma.
Lu ZH; Lv K; Zhang JS; Dai CG; Liu B; Ma XY; He LM; Jia JY; Chen YM; Dai XL; Wang AD; Dong J; Zhang QB; Lan Q; Huang Q
Oncol Rep; 2014 Feb; 31(2):657-64. PubMed ID: 24284913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
